24/7 Market News Snapshot 28 July, 2025 – Avalon GloboCare Corp. Common Stock (NASDAQ:ALBT)

July 28, 2025

DENVER, Colo., 28 July, 2025 (www.247marketnews.com) – (NASDAQ:ALBT) are discussed in this article.
Avalon GloboCare Corp. (NASDAQ:ALBT) is experiencing a noteworthy trading surge, with its stock prices showing a significant increase of approximately 14.14%, rising from an opening value of $2.246 to a current trading price of $2.591. This positive shift comes as the stock shows strong bullish momentum, moving above its previous session close of $2.270. Trading volume has reached 605.20K, reflecting heightened interest among investors, which suggests a potential for continued price appreciation. Traders are closely monitoring key indicators such as moving averages and the Relative Strength Index to assess the sustainability of this upward trend.

In addition to its impressive market performance, Avalon has made significant strides in its commercial strategy by securing a wholesale distribution agreement for its innovative KetoAir™ breathalyzer device. The agreement with Saga Health Corporation aims to incorporate the device into Saga’s Holistic Health Reset Program, particularly designed for first responders. The KetoAir™ breathalyzer measures breath acetone concentration (BrAce), a vital marker for evaluating fat metabolism and ketosis, catering to individuals pursuing ketogenic health management for various purposes, including weight loss and athletic performance enhancement.

Dr. David Jin, President and CEO of Avalon GloboCare, highlighted the significance of this partnership as a major step toward expanding the market presence of the KetoAir™. He expressed enthusiasm about collaborating with Saga Health, whose comprehensive wellness initiatives are set to offer much-needed health resources to first responders. This collaboration not only underscores Avalon’s commitment to innovation in the health sector but also reflects the growing demand for personalized health monitoring tools. With the KetoAir™ now available on major app platforms, Avalon continues to push the boundaries in diagnostic technologies, demonstrating a dedicated mission to enhance health management solutions.

Related news for (ALBT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.